TERT and hepatocellular carcinoma: In a study examining hepatic nodules development in cirrhosis, the hotspot TERT promoter mutations were detected in 6% of the low-grade dysplastic nodules, 19% of the high-grade dysplastic nodules, 61% of early HCC, and 41% of established HCC [15].